SA
Create Free Alerts
Spyre Therapeutics, Inc.SYRENASDAQ
Loading
OverviewIntelligenceCharts
Gross Profit Growth TrendStable
Percentile Rank97
3Y CAGR+378.2%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
+378.2%/yr
Quarterly compound
Percentile
P97
Near historical high
vs 3Y Ago
109.3x
Strong expansion
Streak
1 qtr
Consecutive growthStable
PeriodValue
Q4 2025200.00%
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 20240.00%
Q4 20230.00%
Q3 2023-100.00%
Q2 2023296.57%
Q1 2023-8.70%
Q4 20221.83%
Q3 2022-318.67%
Q2 2022-82.66%
Q1 2022-72.47%
Q4 2021123.35%
Q3 2021-11599.15%
Q2 20210.00%
Q1 20210.00%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%
Q4 20190.00%
Q3 20190.00%
Q2 20190.00%
Q1 20190.00%
Q4 20180.00%
Q3 20180.00%
Q2 20180.00%
Q1 20180.00%
Q4 20170.00%
Q3 20170.00%
Q2 20170.00%
Q1 20170.00%
Q4 20160.00%
Q3 20160.00%
Q2 20160.00%
Q1 20160.00%

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance